INTRODUCTION {#s1}
============

Mantle cell lymphoma (MCL) is a malignant lymphoproliferative B-cell disorder derived from naïve pregerminal center CD5^+^ cells \[[@R1]\]. MCL is strongly associated with the t(11,14) chromosomal translocation leading to overexpression of cyclin D1. Cyclin D1-negative MCL do no express high amounts of cyclin D1 but elevated cyclin D2 or cyclin D3 ones and share the same secondary genetic aberrations that typical MCL supporting the concept that they correspond to the same genetic entity \[[@R1]\]. MCL does not occur spontaneously in mice but experimental mice model have been developed. Old Eμ-cyclin D1 transgenic mice developed CD19^+^IgM^+^CD5^+^CD23^−^ MCL under stimulation by pristine, a pro-inflammatory tumor promoter \[[@R2]\]. Interleukin 14 alpha (IL-14α)/c-*myc* double transgenic mice developed lymphomas reproducing many features of blastoid variant of MCL \[[@R3]\]. Recently we generated two different mice models prone to develop MCL-like lymphomas. The first one uses the Cdk4-Arg24Cys (R24C) mutation that abolishes the ability of all four INK4 members to bind Cdk4. Disruption of Cdk4 regulation by INK4 while c-*myc* is overexpressed in B-cells (in a c-*myc*-3\'RR transgenic background prone to develop Burkitt lymphoma (BL)-like lymphomas \[[@R4]\]) leads to the development (in double mutant c-*myc*-3\'RR/Cdk4^R24C^ mice) of lymphoid malignancies closely resembling human MCL \[[@R5]\]. The second is relevant to the frequent loss of p53 function observed in human lymphomas, underscoring its critical role in suppressing the emergence of incipient tumors. Double mutant c-*myc*-3\'RR/p53^+/−^ mice developed a wide pattern of lymphomas including MCL-like lymphomas \[[@R6]\]. It remains unclear what are the common molecular and genetic pathways explaining the convergence of these two mice models towards the same lymphoma phenotype. In both situations, MCL-like lymphomas express similar membrane B-cell differentiation markers (B220^+^CD19^+^IgM^+^IgD^+^ CD5^+^CD23^−^) but arise with different kinetics (3 months *vs* 6 months for c-*myc*-3\'RR/p53^+/−^ mice and c-*myc*-3\'RR/Cdk4^R24C^ mice, respectively), with a different proteomic signature (Cdk6/cyclin D complexes *vs* Cdk4/cyclin D complexes for c-*myc*-3\'RR/p53^+/−^ mice and c-*myc*-3\'RR/Cdk4^R24C^ mice, respectively), and in relation with a different mutational status (p53 deficiency *vs* disruption of Cdk4 regulation by INK4). Gene arrays have proven effective in establishing molecularly defined subgroups within defined tumor entities. We explored the potential similar biological entity of these two mice models of MCL-like lymphomas by comparing their gene expression profiles.

MATERIAL AND METHODS {#s2}
====================

Our research has been approved by the ethics committee review board of our University (Limoges, France) and hospital (CHU Dupuytren, Limoges, France). Animal works has been conducted according to French laws. c-*myc*-3\'RR transgenic mice are prone to BL-like lymphomas \[[@R4]\]. In c-*myc*-3\'RR mice, c-*myc* is specifically expressed from the pre-B to the mature B-cell stages; the 3\'RR being active in late B cell lymphopoiesis \[[@R7]-[@R9]\]. Generation of c-*myc*-3\'RR/Cdk4^R24C^ and c-*myc*-3\'RR/p53^+/−^ mice in similar genetic background and their MCL-like lymphoma development have been previously reported \[[@R5], [@R6]\]. mRNA was extracted from MCL-like lymphoma cases by sorting tumoral cells with CD19-coupled beads (Miltenyi Biotech, Bergisch Gladbach, Germany). Microarray experiments were done in "Nice - Sophia Antipolis Microarray Facility" (France). Statistical analysis was made with the Bioconductor open source software, particularly its Limma package. The microarray data presented in this article have been submitted to the Gene Expression Omnibus database ([www.ncbi.nlm.nih.gov/geo/](http://www.ncbi.nlm.nih.gov/geo/)) under the accession numbers GSE36808.

RESULTS AND DISCUSSION {#s3}
======================

The gene expression profile of MCL-like lymphomas of c-*myc*-3\'RR/Cdk4^R24C^ mice was compared with the one of c-*myc*-3\'RR/p53^+/−^ mice using an array of 44,000 genes. A Log score \>2, a Log ratio \>2 or \<-2 and a p\<0.05 was used as cut of. Among these 44,000 genes, only 176 significantly differed (Tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}). Noticeably, differential expression of multiple genes involved in growth, metabolism and signalling (97/176, 55.1%, Table [1](#T1){ref-type="table"}), diabetes and obesity (31/176, 17.6%, Table [2](#T2){ref-type="table"}) and cellular architecture (23/176, 13.0%, Table [3](#T3){ref-type="table"}) were found. Thirty two unknown genes significantly differed (32/176, 18.1%, Table [4](#T4){ref-type="table"}). Of note some genes can be found both in Table [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"} and/or [3](#T3){ref-type="table"}.

###### Genes implicated in growth, metabolism and signalling processes

                                                                                                  Log2 ratio   p-value   log score
  -------------- -------------------- ----------------------------------------------------------- ------------ --------- -----------
  Tppp           NM_182839            polymerization promoting protein                            −5.97        0.03      4.48
  Prkcc          NM_011102            protein kinase C, gamma                                     −4.35        0.03      4.28
  Gchfr          NM_177157            GTP cyclohydrolase I feedback regulator                     −3.91        0.03      4.14
  Chit1          NM_027979            chitinase 1 (chitotriosidase)                               −5.14        0.03      4.11
  Ahnak          NM_001039959         nucleoprotein (desmoyokin), TV 3                            −4.48        0.03      3.95
  Trf            NM_133977            transferrin                                                 −4.41        0.03      3.94
  Apoc1          NM_007469            apolipoprotein C-I, TV 1                                    −3.74        0.03      3.94
  Macrod2        NM_028387            MACRO domain containing 2, TV 2                             2.89         0.03      3.56
  Rfx2           NM_009056            regulatory factor X, TV 2                                   −3.31        0.03      3.52
  Ctse           NM_007799            cathepsin E                                                 −4.17        0.03      3.46
  Cdkn2a         NM_009877            cyclin-dependent kinase inhibitor 2A, TV 1                  4.17         0.03      3.45
  Slc40a1        NM_016917            solute carrier family 40, M 1                               −5.21        0.03      3.43
  Igf1           NM_010512            insulin-like growth factor 1, TV 1                          −3.1         0.03      3.43
  Igf2bp3        NM_023670            insulin-like growth factor 2 mRNA binding protein 3         2.85         0.03      3.38
  Slc2a6         NM_172659            solute carrier family 2, M 6                                2.51         0.03      3.31
  Ngfr           NM_033217            nerve growth factor receptor                                −3.13        0.03      3.28
  Camk4          NM_009793            calcium/calmodulin-dependent protein kinase IV              3.42         0.03      3.25
  Rtn4rl1        NM_177708            reticulon 4 receptor-like 1                                 −4.58        0.03      3.19
  Ear11          NM_053113            eosinophil-associated, ribonuclease A family, M 11          −2.64        0.03      3.14
  Ccnb1          NM_172301            cyclin B1                                                   2.9          0.03      3.11
  Rasal1         NM_013832            RAS protein activator like 1 (GAP1 like)                    2.67         0.03      3.10
  As3mt          NM_020577            arsenic (+3 oxidation state) methyltransferase              −2.71        0.03      3.08
  Ppl            NM_008909            periplakin                                                  −2.79        0.03      3.06
  Spic           NM_011461            spi-C transcription factor                                  −3.85        0.03      2.97
  Eif2c2         NM_153178            eukaryotic translation initiation factor 2C                 3.42         0.03      2.95
  Ak4            NM_001177602         adenylate kinase 4, TV 1                                    3.54         0.03      2.93
  Timeless       NM_001164081         timeless homolog (Drosophila),TV 4                          2.57         0.03      2.89
  Rgs12          NM_173402            regulator of G-protein signaling 12, TV 1                   3.1          0.03      2.86
  Ccr3           NM_009914            chemokine (C-C motif) receptor 3                            −2.74        0.03      2.79
  Mrap           NM_029844            melanocortin 2 receptor accessory protein                   −2.36        0.03      2.79
  Cdc20          NM_023223            cell division cycle 20 homolog                              2.26         0.03      2.77
  Adarb1         NM_001024837         adenosine deaminase B1, TV 2                                2.25         0.03      2.75
  Cotl1          NM_028071            coactosin-like 1 (Dictyostelium)                            −2.13        0.03      2.69
  Trip13         NM_027182            thyroid hormone receptor interactor 13                      2.3          0.03      2.65
  Atp6v1c2       NM_133699            ATPase, lysosomal V1 subunit C2, TV 2                       −2.83        0.03      2.58
  Slc43a3        NM_021398            solute carrier family 43, M 3                               3.27         0.03      2.46
  Sbk1           NM_145587            SH3-binding kinase 1                                        −2.45        0.03      2.38
  Vcam1          NM_011693            vascular cell adhesion molecule 1                           −4.91        0.03      2.37
  Kcnj16         NM_010604            potassium inwardly-rectifying channel, subfamily J, M 16    −2           0.03      2.33
  Lmo1           NM_057173            LIM domain only 1                                           2.01         0.03      2.30
  Osbpl5         NM_024289            oxysterol binding protein-like 5, TV 1                      −2.17        0.03      2.30
  Tmco6          NM_028036            transmembrane and coiled-coil domains 6                     −2.01        0.03      2.30
  Serpinb3c      NM_201363            serine (or cysteine) peptidase inhibitor, clade B, M 3C     2.63         0.03      2.25
  Trim11         NM_053168            tripartite motif-containing 11                              −2.06        0.03      2.24
  Slc16a9        NM_025807            solute carrier family 16, M 9                               −2.07        0.03      2.23
  Fxyd6          NM_022004            FXYD domain-containing ion transport regulator 6            2.13         0.03      2.22
  Gstm5          NM_010360            glutathione S-transferase, mu 5                             2.52         0.03      2.19
  Slc34a1        NM_011392            solute carrier family 34 (sodium phosphate), M 1            −2.82        0.03      2.14
  Rnf157         ENSMUST00000149682   ring finger protein 157                                     2.52         0.03      2.124
  Nek2           NM_010892            NIMA (never in mitosis gene a)-related expressed kinase 2   2.57         0.03      2.11
  C6             NM_016704            complement component 6                                      −2.18        0.03      2.05
  H60a           NM_010400            histocompatibility 60a                                      −6.18        0.03      2.04
  septin3        NM_011889            septin 3                                                    −6.18        0.03      2.04
  Ear10          NM_053112            eosinophil-associated, ribonuclease A family, M 10          −2.2         0.03      1.99
  Kctd17         NM_001081367         potassium channel tetramerisation domain containing 17      3.64         0.03      1.91
  Casc4          NM_001205369         cancer susceptibility candidate 4, TV 3                     2.44         0.03      1.89
  Tcp11l2        NM_146008            t-complex 11 like 2                                         −2.88        0.03      1.83
  Mybl2          NM_008652            myeloblastosis oncogene-like 2                              2.16         0.03      1.83
  Prkar2a        NM_008924            protein kinase, cAMP dependent regulatory, type II alpha    2.1          0.03      1.81
  Tcp11          NM_013687            t-complex protein 11, TV 1                                  −2.04        0.03      1.81
  Trerf1         NM_172622            transcriptional regulating factor 1,TV 2                    3.07         0.03      1.80
  Pvrl2          NM_008990            poliovirus receptor-related 2, TV 1                         −4.17        0.03      1.78
  Prkar2b        NM_011158            protein kinase, cAMP dependent regulatory, type II beta     −3.46        0.03      1.78
  Melk           NM_010790            maternal embryonic leucine zipper kinase                    2.23         0.03      1.75
  Cdca3          NM_013538            cell division cycle associated 3                            2.21         0.03      1.74
  B3gnt8         NM_146184            betaGal beta-1,3-N-acetylglucosaminyltransferase 8, TV 1    −2.19        0.03      1.71
  Nradd          NM_026012            neurotrophin receptor associated death domain               2.29         0.03      1.68
  S100a5         NM_011312            S100 calcium binding protein A5                             −2.38        0.03      1.68
  Antxr1         NM_054041            anthrax toxin receptor 1                                    2.25         0.04      1.64
  Pear1          NM_028460            platelet endothelial aggregation receptor 1, TV 1           −2.6         0.04      1.62
  Akap13         ENSMUST00000136989   A kinase (PRKA) anchor protein 13                           −2.23        0.04      1.62
  Ebf3           NM_010096            early B-cell factor 3, TV 3                                 2.86         0.04      1.60
  Tk1            NM_009387            thymidine kinase 1                                          2.46         0.04      1.57
  Rgs11          NM_001081069         regulator of G-protein signaling 11                         −2.22        0.04      1.57
  Gm4910         XM_141816            predicted pseudogene 4910                                   −2.22        0.04      1.56
  Ell3           NM_145973            elongation factor RNA polymerase II-like 3                  −3.12        0.04      1.55
  Etl4           NM_001081006         enhancer trap locus 4, transcript variant c                 3.4          0.04      1.50
  Syce2          NM_027954            synaptonemal complex central element protein 2, TV 2        3.17         0.04      1.47
  LOC100042049   NR_004442            ribosomal protein L22 like 1 pseudogene                     −2.17        0.04      1.38
  Sorcs2         NM_030889            sortilin-related VPS10 domain containing receptor 2         −2.12        0.04      1.38
  Crip2          NM_024223            cysteine rich protein 2                                     −4.51        0.04      1.37
  Wnk2           NM_029361            WNK lysine deficient protein kinase 2                       3.76         0.04      1.36
  Samd9l         NM_010156            sterile alpha motif domain containing 9-like                −2.09        0.04      1.36
  Hoxb6          NM_008269            homeobox B6                                                 −2.23        0.04      1.35
  Rpl22l1        NM_026517            ribosomal protein L22 like 1                                −2.02        0.04      1.34
  Crip1          NM_007763            cysteine-rich protein 1                                     −4.05        0.04      1.31
  Enkur          NM_027728            enkurin                                                     −3.01        0.04      1.30
  Ear2           NM_007895            eosinophil-associated, ribonuclease A family,M 2            −3.45        0.04      1.29
  Cdca5          NM_026410            cell division cycle associated 5                            2.04         0.04      1.23
  Mrc1           NM_008625            mannose receptor, C type 1                                  −2.61        0.04      1.22
  Ear12          NM_001012766         eosinophil-associated, ribonuclease A family, M 12          −2.29        0.04      1.20
  Ehf            NM_007914            ets homologous factor                                       2.89         0.04      1.16
  Ssbp2          NM_024272            single-stranded DNA binding protein 2, TV 2                 2.49         0.04      1.14
  Phlda3         NM_013750            pleckstrin homology-like domain, family A, M 3              −4.08        0.04      1.14
  Whsc1          NM_001177884         Wolf-Hirschhorn syndrome candidate 1, TV 3                  2.16         0.04      1.11
  Gm2a           NM_010299            GM2 ganglioside activator protein                           −2.21        0.04      1.11
  Armc2          NM_001034858         armadillo repeat containing 2                               3.03         0.04      1.09

Comparison of transcriptoma of c-*myc*-3\'RR/Cdk4^R24C^ and c-*myc*-3\'RR/p53^+/−^ MCL-like lymphomas. Among these 44,000 genes, 176 significantly differed. A Log score \>2, a Log ratio \>2 or \<−2 and a p\<0.05 was used as cut of. A: c-*myc*-3\'RR/p53^+/−^ MCL-like lymphomas; B: c-*myc*-3\'RR/Cdk4^R24C^ MCL-like lymphomas; M: member; TV: transcript variant.

###### Genes implicated in diabetes and obesity

                                                                                             Log2 ratio   p-value   log score
  --------- -------------------- ----------------------------------------------------------- ------------ --------- -----------
  Abcc8     NM_011510            ATP-binding cassette, sub-family C, M 8                     4.11         0.03      4.02
  Ahnak     NM_001039959         nucleoprotein (desmoyokin), TV 3                            −4.48        0.03      3.95
  Trf       NM_133977            transferrin                                                 −4.41        0.03      3.94
  Apoc1     NM_007469            apolipoprotein C-I, TV 1                                    −3.74        0.03      3.94
  Cr2       NM_007758            complement receptor 2                                       −3.62        0.03      3.77
  Cdkn2a    NM_009877            cyclin-dependent kinase inhibitor 2A, TV 1                  4.17         0.03      3.45
  Gfra2     NM_008115            glial derived neurotrophic factor family receptor alpha 2   −4.48        0.03      3.44
  Igf1      NM_010512            insulin-like growth factor 1, TV 1                          −3.1         0.03      3.43
  Igf2bp3   NM_023670            insulin-like growth factor 2 mRNA binding protein 3         2.85         0.03      3.38
  Hmox1     NM_010442            heme oxygenase (decycling) 1                                −3.87        0.03      3.29
  Gstt1     NM_008185            glutathione S-transferase, theta 1                          2.7          0.03      3.17
  Rcan2     NM_207649            regulator of calcineurin 2, TV 1                            3.87         0.03      3.16
  Tub       NM_021885            tubby candidate gene                                        −3.29        0.03      3.13
  Osbpl3    NM_001163645         oxysterol binding protein-like 3, TV 2                      2.49         0.03      2.99
  Mgll      NM_001166251         monoglyceride lipase, TV 1                                  2.1          0.03      2.85
  Srd5a1    NM_175283            steroid 5 alpha-reductase 1                                 3.31         0.03      2.42
  Rgs16     NM_011267            regulator of G-protein signaling 16                         2.96         0.03      2.23
  Cbs       NM_144855            cystathionine beta-synthase, TV 1                           3.82         0.03      2.19
  Alox5     NM_009662            arachidonate 5-lipoxygenase                                 2.18         0.03      2.19
  Pdk1      NM_172665            pyruvate dehydrogenase kinase, isoenzyme 1                  2.68         0.03      1.96
  Me1       NM_001198933         malic enzyme 1, TV 2                                        2.49         0.03      1.90
  Mef2b     NM_001045484         myocyte enhancer factor 2B, TV 2                            3.17         0.03      1.88
  Foxp2     ENSMUST00000118133   forkhead box P2 \[ENSMUST00000118133\]                      2.08         0.03      1.79
  Aurka     NM_011497            aurora kinase A                                             2.07         0.03      1.70
  Ube2e2    NM_144839            ubiquitin-conjugating enzyme E2E 2                          3.03         0.03      1.66
  Bmpr1a    NM_009758            bone morphogenetic protein receptor, type 1A                3.25         0.04      1.45
  Kcnj10    NM_001039484         potassium inwardly-rectifying channel, subfamily J, M 10    −3.04        0.04      1.39
  Hfe       NM_010424            hemochromatosis                                             −2.07        0.04      1.33
  Pdss1     NM_019501            prenyl (solanesyl) diphosphate synthase, subunit 1          2.06         0.04      1.07
  Hpgd      NM_008278            hydroxyprostaglandin dehydrogenase 15                       −2.94        0.04      1.04
  Fabp5     NM_010634            fatty acid binding protein 5                                2.65         0.04      1.02

Comparison of transcriptoma of c-*myc*-3\'RR/Cdk4^R24C^ and c-*myc*-3\'RR/p53^+/−^ MCL-like lymphomas. Among these 44,000 genes, 176 significantly differed. A Log score \>2, a Log ratio \>2 or \<−2 and a p\<0.05 was used as cut of. A: c-*myc*-3\'RR/p53^+/−^ MCL-like lymphomas; B: c-*myc*-3\'RR/Cdk4^R24C^ MCL-like lymphomas; M: member; TV: transcript variant.

###### Genes implicated in cellular architecture

                                                                                  Log2 ratio   p-value   log score
  ---------- -------------- ----------------------------------------------------- ------------ --------- -----------
  Ahnak      NM_001039959   nucleoprotein (desmoyokin), TV 3                      −4.48        0.03      3.95
  Myadm      NM_016969      myeloid-associated differentiation marker, TV 4       −5.5         0.03      3.69
  Stab2      NM_138673      stabilin 2                                            −3.39        0.03      3.50
  Fcna       NM_007995      ficolin A                                             −4.8         0.03      3.46
  Avil       NM_009635      advillin                                              4.05         0.03      3.42
  Ctnnbip1   NM_023465      catenin beta interacting protein 1, TV 1              2.32         0.03      2.85
  Ncan       NM_007789      neurocan                                              2.23         0.03      2.78
  Kif18b     NM_197959      kinesin family member 18B                             2.17         0.03      2.68
  Pcolce2    NM_029620      procollagen C-endopeptidase enhancer 2                −2.11        0.03      2.61
  Spock2     NM_052994      sparc/osteonectin                                     2.36         0.03      2.50
  Thbs3      NM_013691      thrombospondin 3                                      −4.07        0.03      2.37
  Lmnb1      NM_010721      lamin B1                                              2.01         0.03      2.30
  Zwilch     NM_026507      Zwilch, kinetochore associated                        2.25         0.03      2.19
  Cd97       NM_011925      CD97 antigen, TV 1                                    −3.62        0.03      2.07
  Mtus2      NM_029920      microtubule associated tumor suppressor candidate 2   −4.03        0.03      1.95
  Cenpi      NM_145924      centromere protein I                                  2.11         0.03      1.94
  Mef2b      NM_001045484   myocyte enhancer factor 2B, TV 2                      3.17         0.03      1.88
  Dscaml1    NM_001081270   down syndrome cell adhesion molecule-like 1           −2.58        0.03      1.81
  Tubb2b     NM_023716      tubulin, beta 2B                                      −4.58        0.03      1.75
  Spc25      NM_001199123   NDC80 kinetochore complex component, TV 1             2.23         0.04      1.56
  Mtap2      NM_001039934   microtubule-associated protein 2, TV 1                2.24         0.04      1.56
  Stmn1      NM_019641      stathmin 1                                            2.77         0.04      1.39
  Slmo1      NM_144867      slowmo homolog 1                                      4.5          0.04      1.17

Comparison of transcriptoma of c-*myc*-3\'RR/Cdk4^R24C^ and c-*myc*-3\'RR/p53^+/−^ MCL-like lymphomas. Among these 44,000 genes, 176 significantly differed. A Log score \>2, a Log ratio \>2 or \<-2 and a p\<0.05 was used as cut of. A: c-*myc*-3\'RR/p53^+/−^ MCL-like lymphomas; B: c-*myc*-3\'RR/Cdk4^R24C^ MCL-like lymphomas; M: member; TV: transcript variant.

###### Unknown genes

                                                                                               Log2 ratio   p-value   log score
  -------------------- --------------- ------------------------------------------------------- ------------ --------- -----------
  Pqlc1                NM_001164420    PQ loop repeat containing 1, TV 2                       −3.62        0.03      3.97
  NAP101497-1          same            unknown                                                 −2.54        0.03      3.09
  LOC100502767         XR_104684       hypothetical LOC100502767                               3.01         0.03      3.04
  A_55_P1973560        same            unknown                                                 2.29         0.03      2.99
  Ng23                 NM_023893       Ng23 protein                                            4.68         0.03      2.92
  A_55_P2137023        same            unknown                                                 2.64         0.03      2.87
  ENSMUST00000103452   same            predicted gene 16886                                    −2.55        0.03      2.75
  Frmd5                NM_172673       FERM domain containing 5                                2.51         0.03      2.56
  4931429I11Rik        NM_001081121    RIKEN cDNA 4931429I11 gene                              −4.04        0.03      2.46
  5730416F02Rik        NR_033596       RIKEN cDNA 5730416F02 gene                              −2.66        0.03      2.28
  ENSMUST00000098678   same            RIKEN cDNA D930028M14 gene                              −2.44        0.03      2.16
  ENSMUST00000103381   same            predicted gene 16944                                    −2.54        0.03      2.15
  ENSMUST00000103341   same            predicted gene 16729                                    −5.03        0.03      2.00
  Clip3                NM_001081114    CAP-GLY domain containing linker protein 3              3.96         0.03      1.89
  ENSMUST00000103314   same            predicted gene 16798                                    −4.33        0.03      1.80
  ENSMUST00000103348   same            predicted gene 1502                                     −4.52        0.03      1.76
  Cd2                  NM_013486       CD2 antigen                                             −2.97        0.03      1.72
  9030409G11Rik        NM_001109685    RIKEN cDNA 9030409G11 gene, TV 3                        2.64         0.03      1.69
  ENSMUST00000103444   same            predicted gene 16971                                    −2.46        0.03      1.69
  Lrrc23               NM_013588       leucine rich repeat containing 23                       −3.82        0.03      1.67
  Sssca1               NM_020491       Sjogren\'s syndrome/scleroderma autoantigen 1 homolog   2.06         0.04      1.64
  ENSMUST00000103316   same            predicted gene 5571                                     −3.83        0.04      1.59
  Gm3227               XR_105936       predicted gene 3227                                     −2.99        0.04      1.46
  C77080               NM_001033189    expressed sequence C77080                               −3.6         0.04      1.44
  2810025M15Rik        NR_027984       RIKEN cDNA 2810025M15 gene                              2.05         0.04      1.25
  2200002J24Rik        NM_026961       RIKEN cDNA 2200002J24 gene                              2.24         0.04      1.25
  6030419C18Rik        NM_176921       RIKEN cDNA 6030419C18 gene                              2.42         0.04      1.20
  ENSMUST00000103493   same            predicted gene 16694                                    −2.37        0.04      1.16
  A_55_P2040519        A_55_P2040519   unknown                                                 2.63         0.04      1.14
  A_55_P2121294        same            unknown                                                 −2.46        0.04      1.12
  D330028D13Rik        NM_172727       RIKEN cDNA D330028D13 gene, TV 1                        2.05         0.04      1.11
  LOC100502627         BC058714        cDNA clone IMAGE:6842867                                2.26         0.04      1.01

Comparison of transcriptoma of c-*myc*-3\'RR/Cdk4^R24C^ and c-*myc*-3\'RR/p53^+/−^ MCL-like lymphomas. Among these 44,000 genes, 176 significantly differed. A Log score \>2, a Log ratio \>2 or \<-2 and a p\<0.05 was used as cut of. A: c-*myc*-3\'RR/p53^+/−^ MCL-like lymphomas; B: c-*myc*-3\'RR/Cdk4^R24C^ MCL-like lymphomas; M: member; TV: transcript variant.

Differences concerning genes involved in diabetes and obesity (such as Abcc8, Trf, apoc1 and IGF-1) appear directly linked to the Cdk4^R24C^ mutation since loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasia \[[@R10]\]. The metabolic and endocrinic changes resulting from diabetes and obesity may dysregulate DNA repair, gene functions and cell mutation rate favouring neoplastic transformation and leading to hematologic malignancy and cancer \[[@R11]\]. For example IGF-1 (insulin growth factor 1) transcripts are markedly elevated in MCL-like lymphomas of c-*myc*-3\'RR/Cdk4^R24C^ mice; IGF-1 involvement being well documented in cancer \[[@R11]\]. Differences concerning genes implicated in the growth and signalling processes could be explained by the Cdk4^R24C^ and p53 mutations themselves. For example, up-regulation of the cell cycle regulatory genes Ccnb1 and Cdc20 in MCL-like lymphomas of c-*myc*-3\'RR/p53^+/−^ mice appear directly linked to the p53^+/−^ mutation that increases the rate and occurrence of c-*myc*-induced lymphomas \[[@R6], [@R12]\]. Indeed, Ccnb1 overexpression in lymphomas is caused by non-functional p53 \[[@R13]\], while Cdc20 is negatively regulated by p53 \[[@R14]\]. In turn the down regulation of the Cdk4 inhibitor Cdkn2a in MCL-like lymphomas of c-*myc*-3\'RR/Cdk4^R24C^ mice appears related to its inefficiency in Cdk4^R24C^ mice. As a consequence of a higher proliferation rate, several genes implicated in cell metabolism (such as Adarb1, Lmo1, AK4, Slc2a4) and nuclear membrane or chromosome stability (such as Lmnb1 and Cenpi) are higher in MCL-like lymphomas of c-*myc*-3\'RR/p53^+/−^ mice than in MCL-like lymphomas of c-*myc*-3\'RR/Cdk4^R24C^ mice. Finally and also linked to a higher rate of proliferation, several differences are found concerning genes implicated in cellular architecture especially on the actin and microtubule cytoskeletons (such as advillin Kif18b, Mtus2, Tubb2b, Mtap2, Stmn1), key players that underpin growth processes \[[@R15]\].

MCL-like lymphomas of c-*myc*-3\'RR/p53^+/−^ mice are more aggressive than those of c-*myc*-3\'RR/Cdk4^R24C^ mice despite similar flow cytometry profiles \[[@R5], [@R6]\]. Comparison of their gene expression profiles explains this difference by a marked overexpression of several cell cycle regulatory genes. Gene expression profiles do not highlight other specific differences other than those in relation with their specific mutational status (*i.e.,* Cdk4^R24C^ or p53 mutations). We propose that similarly to typical human MCL and its blastoid or cyclin-D1 variants that correspond to the same genetic entity \[[@R1]\], MCL-like lymphomas of c-*myc*-3\'RR/p53^+/−^ mice and c-*myc*-3\'RR/Cdk4^R24C^ mice represent a spectrum of the same entity. Our results indicate that deregulation of two different signalling pathways within a single B cell entity can lead to the emergence of a unique lymphoma phenotype carrying different oncogenic stigmas. These different oncogenic stigmas explain differences concerning the proliferative and/or apoptotic status of the lymphoma and thus potential differential responses to treatment. Tumor transcriptoma analysis and tumor DNA sequence analysis could thus become useful laboratory tests paving the way towards personalized treatments \[[@R16]\].
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